Ellen Farr

Ellen Farr

Auto-generated profile, based on publicly available information

Ellen Farr

Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago) Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2021 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
EFEllen Farr
Ellen Farr
AWAlexis R. Wolfe
Alexis R. Wolfe
SDSwati Deshmukh
Swati Deshmukh
LRLeslie Rydberg
Leslie Rydberg
RSRachna Soriano
Rachna Soriano
CFColin Franz
Colin Franz
Many survivors from severe coronavirus disease 2019 (COVID‐19) suffer from persistent dyspnea and fatigue long after resolution of the active infection. In a cohort of 21 consecutive severe post‐COVID‐19 survivors admitted to an inpatient rehabilitation hospital, 16 (76%) of them had at least one sonographic abnormality of diaphragm muscle structure or function. This corresponded to a significant reduction in diaphragm muscle contractility as represented by thickening ratio (muscle thickness at maximal inspiration/end‐expiration) for the post‐COVID‐19 compared to non‐COVID‐19 cohorts. These findings may shed new light on neuromuscular respiratory dysfunction as a contributor to prolonged functional impairments after hospitalization for post‐COVID‐19.

5 October 2022 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
RSRichard Severin
Richard Severin
CFColin Franz
Colin Franz
EFEllen Farr
Ellen Farr
CMCristiane Meirelles
Cristiane Meirelles
RARoss Arena
Ross Arena
Mark FaghyMark Faghy
Mark Faghy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in multiorgan damage primarily mediated by viral infiltrationviaangiotensin-converting enzyme-2 receptors on the surface of cells. A primary symptom for many patients is exertional dyspnoea which may persist even beyond recovery from the viral infection. Respiratory muscle (RM) performance was hypothesised as a contributing factor to the severity of coronavirus disease 2019 (COVID-19) symptoms, such as dyspnoea, and outcomes. This was attributed to similarities between patient populations at elevated risk for severe COVID-19 symptoms and those with a greater likelihood of baseline RM weakness and the effects of prolonged mechanical ventilation. More recent evidence suggests that SARS-CoV-2 infection itself may cause damage to the RM, and many patients who have recovered report persistent dyspnoea despite having mild cases, normal lung function or undamaged lung parenchyma. These more recent findings suggest that the role of RM in the persistent dyspnoea due to COVID-19 may be more substantial than originally hypothesised. Therefore, screening for RM weakness and providing interventions to improve RM performance appears to be important for patients with COVID-19. This article will review the impact of SARS-CoV-2 infection on RM performance and provide clinical recommendations for screening RM performance and treatment interventions.

19 January 2021 in PM&R
Verified
Journal Article
Closed access
PDF file
EFEllen Farr
Ellen Farr
KAKathryn Altonji
Kathryn Altonji
RHRichard L. Harvey
Richard L. Harvey

9 August 2022 in PM&R
Verified
Journal Article
Closed access
EFEllen Farr
Ellen Farr
SLSujin Lee
Sujin Lee
SMSusan Maltser
Susan Maltser
MVMonica Verduzco-Gutierrez
Monica Verduzco-Gutierrez
LSLauren T. Shapiro
Lauren T. Shapiro

27 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
CFColin Franz
Colin Franz
NMNikhil K. Murthy
Nikhil K. Murthy
GMGeorge Ross Malik
George Ross Malik
JKJean Won Kwak
Jean Won Kwak
DDDom D’andrea
Dom D’andrea
John A. RogersJohn A. Rogers
John A. Rogers
We diagnosed 66 peripheral nerve injuries in 34 patients who survived severe COVID-19. We combine our latest data with published case series re-analyzed here (117 nerve injuries; 58 patients) to provide a comprehensive accounting of lesion sites. The most common are ulnar (25.1%), common fibular (15.8%), sciatic (13.1%), median (9.8%), brachial plexus (8.7%) and radial (8.2%) nerves at sites known to be vulnerable to mechanical loading. Protection of peripheral nerves should be prioritized in the care of COVID-19 patients. To this end, we report proof of concept data of a wearable, wireless pressure sensor to provide real time monitoring in the intensive care unit setting.

11 December 2020 in medRxiv
Verified
Preprint
Open access
PDF file
EFEllen Farr
Ellen Farr
AWAlexis R. Wolfe
Alexis R. Wolfe
SDSwati Deshmukh
Swati Deshmukh
LRLeslie Rydberg
Leslie Rydberg
RSRachna Soriano
Rachna Soriano
CFColin Franz
Colin Franz
Many survivors from severe coronavirus disease 2019 (COVID-19) suffer from persistent dyspnea and fatigue long after resolution of the active infection. In a cohort of 25 consecutive COVID-19 survivors admitted to an inpatient rehabilitation hospital (76% male), 80% of them had at least one sonographic abnormality of diaphragm muscle structure or function. Specifically, when compared to established normative data, 76% had reduced diaphragm thickening ratio (impaired contractility), and 20% patients had reduced diaphragm muscle thickness (atrophy). These findings support neuromuscular respiratory dysfunction as a highly prevalent underlying cause for prolonged functional impairments after hospitalization for COVID-19.